Holocene Advisors
KYMR icon

Holocene Advisors’s Kymera Therapeutics KYMR Stock Holding History

Holocene Advisors’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73M Sell
636,579
-200,180
-24% -$17.2M 0.16% 160
2026
Q1 		$69.7M Buy
836,759
+75,550
+10% +$5.98M 0.17% 146
2025
Q4 		$59.2M Sell
761,209
-79,124
-9% -$5.34M 0.12% 188
2025
Q3 		$47.6M Buy
+840,333
New +$37.9M 0.11% 182

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Holocene Advisors's KYMR Position: Q2 2026 in Review

Holocene Advisors reduced its Kymera Therapeutics (KYMR) stake by 24% in Q2 2026, selling an estimated $17.2M and leaving 636,579 shares worth $73M. The position accounts for 0.16% of the portfolio, ranked #160.

Holocene Advisors first reported a position in KYMR in Q3 2025 and has held it in 4 quarters since. 277 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Holocene Advisors held 636,579 shares of Kymera Therapeutics worth $73M as of Q2 2026.
  • Holocene Advisors sold 200,180 Kymera Therapeutics shares in Q2 2026, an estimated $17.2M.
  • Kymera Therapeutics made up 0.16% of Holocene Advisors's portfolio in Q2 2026, its #160 holding.
  • Holocene Advisors first reported a position in Kymera Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 277 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.